Abstract
EP21 Tumour necrosis factor inhibitor for the treatment of refractory extra-pulmonary disease including sarcoid arthritis and myositis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1093/rap/rkaa052.020
Copy DOIJournal: Rheumatology Advances in Practice | Publication Date: Oct 1, 2020 |
Citations: 1 | License type: CC BY 4.0 |
EP21 Tumour necrosis factor inhibitor for the treatment of refractory extra-pulmonary disease including sarcoid arthritis and myositis
Join us for a 30 min session where you can share your feedback and ask us any queries you have